Sameer Parikh

Sameer A. Parikh, MBBS, is a Consultant and an Assistant Professor of Medicine and Oncology in the Division of Hematology at Mayo Clinic, Rochester, Minnesota. After completing his medical school training from Seth G.S. Medical School in Mumbai, India, Dr. Parikh pursued his internal medicine residency training from St. Francis Hospital, Evanston, IL, and a fellowship in Hematology/Oncology at Mayo Clinic, Rochester, Minnesota. He also spent one year as a research trainee in the Department of Leukemia at the University of Texas MD Anderson Cancer Center. Subsequently, he was invited to serve as faculty in the Division of Hematology at Mayo Clinic, Rochester; and is a very active and enthusiastic researcher within the Chronic Lymphocytic Leukemia (CLL) Disease Oriented Group.

He is a recipient of numerous awards, including the Shannon Timmins Leukemia Fellowship Award, Mayo Clinic Department of Medicine Career Development Award, Lymphoma SPORE Career Development Award, Mayo Clinic Paul Calabresi Program in Translational Research Scholar Award (K12 CA090628), and the Mayo Clinic K2R Career Development Award.

His research is focused in evaluating the role of prognostic factors and novel agents in chronic lymphocytic leukemia. He is a Principal Investigator of several investigator-initiated and industry-sponsored clinical trials. He is also the Principal Investigator of the Mayo Clinic CLL database, which includes all patients with a diagnosis of CLL seen in the Division of Hematology at Mayo Clinic in Rochester, MN since 1995 who permit their records be used for research purposes and which is linked to the Mayo Clinic CLL tissue bank. Finally, he is also a co-investigator in many R01 studies that are funded by the National Institutes of Health.

He is a passionate educator and has presented his work both at national and international forums. He has authored over 100 peer-reviewed publications in prestigious journals including New England Journal of Medicine, Journal of Clinical Oncology, Blood, Leukemia, Haematologica, American Journal of Hematology and the British Journal of Hematology. He is an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and the Eastern Co-operative Oncology (ECOG-ACRIN).